Clinical trials
Phase 3 Retinitis Pigmentosa trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 4 |
| Not yet recruiting | 2 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ankara Universitesi Teknokent | 2 |
| Nacuity Pharmaceuticals, Inc. | 2 |
| National Eye Institute (NEI) | 2 |
| Carol Weigel DiFranco | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Johns Hopkins University | 1 |
| MeiraGTx Ocular UK Ltd | 1 |
| Ocugen | 1 |
| R-Tech Ueno, Ltd. | 1 |
| Spark Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Retinitis Pigmentosa | 14 |
| Usher Syndromes | 3 |
| Leber Congenital Amaurosis | 1 |
| Retinal Diseases | 1 |
Trials
Showing 26 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.